APSR2026-469

 
Regular
Submitted
Oral Presentation
AO10-003
 
 
 
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

ERIKO KINOSHITA * Fukuoka University Hospital Department of Respiratory Medicine Fukuoka Japan
Toyoshi Yanagihara - Fukuoka University Hospital Department of Respiratory Medicine Fukuoka Japan National Hospital Organization Fukuoka National Hospital Department of Respiratory Medicine Fukuoka Japan
Masaki Fujita - Fukuoka University Hospital Department of Respiratory Medicine Fukuoka Japan
Makoto Yoshida - National Hospital Organization Fukuoka National Hospital Department of Respiratory Medicine Fukuoka Japan
-
-
-
-
-
-
-
-
-
-
-
Presenting Author Details
ERIKO
KINOSHITA
kinoshtaeriko08@gmail.com
+818039425743
31-40
Japan
Original Research
Atopic dermatitis is associated with younger age at hypersensitivity pneumonitis diagnosis: a national and global database study
Maximum 25 words
Abstract Content

Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease caused by inhaled antigens.

Atopic dermatitis (AD) is characterized by skin barrier dysfunction and may facilitate epicutaneous sensitization to environmental antigens. We hypothesized that AD is associated with younger age at HP diagnosis.

We analyzed the JMDC claims database in Japan (2014-2023) and identified patients with HP. Age at first recorded HP diagnosis was compared between patients with and without AD. Subgroup analyses were performed by sex andasthma status. External validation was conducted using the TriNetX Global Collaborative Network, wherepropensity score matching for age and sex was used to compare HP risk in adults with and without AD.

In JMDC, 19,215 patients with HP were identified, including 440 (2.3%) with AD. Patients with AD were younger at first HP diagnosis than those without AD (65.4 years [SD 17.1] vs 70.1 years [SD 13.9], p<0.001). This association remained significant in men, women, and patients without asthma. Among patients in whom AD preceded HP, the difference also persisted (66.3 years [SD 18.4] vs 70.1 years [SD 13.9], p=0.010). In TriNetX, adult patients with AD had a higher risk of HP after propensity score matching than matched patients without AD (risk ratio 1.91, 95% confidence interval 1.612.27, p<0.0001). Among patients with HP, those with AD were also younger at diagnosis(62.2 years [SD 22.2] vs 68.6 years [SD 16.3], p<0.0001).

AD was associated with younger age at HP diagnosis in both Japanese and global datasets and with increased HP risk in the global validation cohort. Impaired skin barrier function and epicutaneous sensitization may contribute to earlier development of HP.

 
 
 
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
hypersensitivity pneumonitis; atopic dermatitis; epicutaneous sensitization
maximum 3 keywords and no abbreviations, separated by commas
This work was supported by the Kakihara Science and Technology Foundation (Grant for Advanced Science and Technology Collaborative Research, fiscal year 2022.) The authors declare no conflict of interest.
290